Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
44
ORKA Quote, Financials, Valuation and Earnings
Last price:
$15.38
Seasonality move
:
-11.9%
Day range:
$14.03 - $14.85
52-week range:
$5.49 - $52.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.53x
Volume:
100.1K
Avg. volume:
288K
1-year change:
-65.26%
Market cap:
$554.1M
Revenue:
--
EPS (TTM):
-$2.86
Earnings Data
Next earnings date for ORKA
Jul 22
2025
Most recent earnings per share
-$0.40
Beat by $0.08
(May 14/2025)
Consensus Estimate
-$0.48
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ORKA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 | -- | -- | -- | -$0.48 | -- |
| 07/22/2025 | Q2 | -- | -- | -- | -$0.43 | -- |
| 05/14/2025 | Q1 | -- | -- | -$0.40 | -$0.48 | $0.08 |
| 03/06/2025 | Q4 | -- | -- | -- | -$0.98 | -- |
| 11/13/2024 | Q3 | -- | -- | -$1.46 | -$0.32 | -$1.14 |
| 06/30/2024 | Q2 | -- | -- | -$0.76 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.24 | -- | -- |
Oruka Therapeutics Earnings Questions
-
How Much did Oruka Therapeutics Generate in Revenue Last Quarter?
Oruka Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Oruka Therapeutics Beat Earnings Last Quarter?
Oruka Therapeutics announced earnings per share of -$0.40 which represents a beat of analyst forecast a -$0.48 per share.
-
Is Oruka Therapeutics Profitable?
Oruka Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Oruka Therapeutics EPS Next Year?
Oruka Therapeutics's earnings are forecast to grow from -- per share to -$2.72 per share next year representing an increase of --.
-
When is Oruka Therapeutics's Earnings Date?
Oruka Therapeutics's next earnings date is July 22, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
